Visual BOLD Response in Late Blind Subjects with Argus II Retinal Prosthesis. [PDF]
PLoS Biology, 2016 Retinal prosthesis technologies require that the visual system downstream of the retinal circuitry be capable of transmitting and elaborating visual signals.
E Castaldi +5 more
doaj +7 more sources
The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients. [PDF]
BMC Ophthalmol, 2014 This is the final version of the article. Available from the publisher via the DOI in this record.BACKGROUND: Retinitis Pigmentosa (RP) is a hereditary genetic disease causing bilateral retinal degeneration.
Vaidya A +7 more
europepmc +10 more sources
Beyoglu Eye Journal, 2017 The Argus II Retinal Prosthesis System (Second Sight Medical Products, Inc., Sylmar, CA, USA) is the first US Food and Drug Administration-approved retinal implant.
İrfan Perente +2 more
doaj +3 more sources
Long-term visual outcomes and rehabilitation in Usher syndrome type II after retinal implant Argus II [PDF]
BMC Ophthalmology, 2018 Background The aim of this article is to describe visual outcomes and posterior rehabilitation of the first Usher syndrome type II (USH2) patient receiving an Argus II (®) prosthesis.
Jeroni Nadal, María Iglesias
doaj +2 more sources
Endoscope-Assisted and Controlled Argus II Epiretinal Prosthesis Implantation in Late-Stage Retinitis Pigmentosa: A Report of 2 Cases [PDF]
Case Reports in Ophthalmology, 2016 Several different approaches for restoring sight in subjects who are blind due to outer retinal degeneration are currently under investigation, including stem cell therapy, gene therapy, and visual prostheses.
Emin Özmert, Sibel Demirel
doaj +2 more sources
Argus II retinal prosthesis system: a review of patient selection criteria, surgical considerations, and post-operative outcomes [PDF]
Clinical Ophthalmology, 2018 Avni P Finn, Dilraj S Grewal, Lejla Vajzovic Department of Ophthalmology, Duke University Eye Center, Durham, NC, USA Abstract: Retinitis pigmentosa (RP) is a group of heterogeneous inherited retinal degenerative disorders characterized by progressive ...
Finn AP, Grewal DS, Vajzovic L
doaj +2 more sources
Brain-computer interface commercialization [PDF]
Journal of NeuroEngineering and RehabilitationBackground Brain-computer interfaces (BCIs) have emerged as powerful tools to restore neurological function lost due to injury or degeneration. Despite scientific advancements, successful commercialization remains challenging.
Jackson Powell, Anson Zhou
doaj +2 more sources
Argus II retinal prosthesis malrotation and repositioning with intraoperative optical coherence tomography in a posterior staphyloma [PDF]
Clinical Ophthalmology, 2015 Michael I Seider, Paul Hahn Duke University Eye Center, Durham, NC, USA Introduction: The Argus II retinal prosthesis may improve visual function in patients with severe vision loss from retinitis pigmentosa.
Seider MI, Hahn P
doaj +2 more sources
Orphan medical devices: addressing the regulatory and access gaps in the EU and US [PDF]
Frontiers in Public HealthBackgroundOrphan medical devices remain the blind spot of rare disease policy. While the United States has recognized them since 1990 through the Humanitarian Use Device (HUD) and Humanitarian Device Exemption (HDE) framework, the European Union only ...
Sanae Akodad +4 more
doaj +2 more sources
Can bionic eyes restore vision? Breakthroughs, challenges, and future frontiers in ophthalmology – A comprehensive review [PDF]
Journal of Biological EngineeringBionic eye technology aims to restore partial vision in individuals with severe visual impairment by artificially stimulating the visual system. Primary approaches involve the use of retinal implants, optic nerve stimulation, and cortical visual ...
Kai-Yang Chen +2 more
doaj +2 more sources